Agios Pharmaceuticals, Inc. (AGIO) vs Trevi Therapeutics, Inc. (TRVI)
- Agios Pharmaceuticals, Inc. AGIO 31.59 −0.54%
- Trevi Therapeutics, Inc. TRVI 13.65 +0.22%
Agios Pharmaceuticals, Inc. and Trevi Therapeutics, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Trevi Therapeutics, Inc. are of similar size ($1.9B and $1.9B). Trevi Therapeutics, Inc. has the higher net margin (0.00% vs −264.8%) and the lower return on invested capital (−1,309.1% vs −75.0%). Across the 13 metrics below, Trevi Therapeutics, Inc. leads on 9 and Agios Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | AGIO | TRVI | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.81% | 0.00% | 67.24% |
| Operating margin | (297.72%) | 0.00% | 0.00% |
| Net margin | (264.76%) | 0.00% | 0.00% |
| Free cash flow margin | (238.54%) | 0.00% | 0.00% |
| Return on equity | (32.95%) | (24.67%) | (50.28%) |
| Return on assets | (30.44%) | (23.82%) | (45.89%) |
| Return on invested capital | (75.02%) | (1,309.12%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack